The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of bosutinib in later-line patients (pts) with chronic myeloid leukemia (CML): A sub-analysis from the phase 4 BYOND trial.
 
Carlo Gambacorti-Passerini
Honoraria - Pfizer
Consulting or Advisory Role - Bristol Myers Squibb Foundation
Research Funding - Pfizer
 
Tim H. Brümmendorf
Honoraria - Janssen-Cilag; Merck; Novartis; Pfizer
Consulting or Advisory Role - Janssen-Cilag; Novartis; Pfizer
Research Funding - Novartis; Pfizer
 
Thomas Ernst
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
 
Eric Leip
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Simon Purcell
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Andrea Viqueira
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Francis J. Giles
Employment - Actuate Therapeutics
Stock and Other Ownership Interests - Actuate Therapeutics
 
Gianantonio Rosti
Speakers' Bureau - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
 
Andreas Hochhaus
Research Funding - Bristol-Myers Squibb; Incyte; Novartis; Pfizer